Treatment of Orthostatic Intolerance - Related Studies - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Treatment of Orthostatic Intolerance

This study is currently recruiting participants.

Study NCT00262470 Information provided by Vanderbilt University

First Received: December 5, 2005 Last Updated: June 23, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Tachycardia
Chronic Orthostatic Intolerance

Additional conditions recognized in this trial

Mitral Valve Prolapse
Neurocirculatory Asthenia

More general conditions related to this trial

Anxiety Disorders
Arrhythmias, Cardiac
Cardiovascular Diseases
Heart Diseases
Heart Valve Diseases
Heart Valve Prolapse
Mental Disorders
Pathologic Processes

Additional drug interventions recognized in this trial

Isosorbide
Isosorbide-5-mononitrate

More general drug interventions related to this trial

Adrenergic Agents
Adrenergic Agonists
Adrenergic alpha-Agonists
Adrenergic Antagonists
Adrenergic beta-Antagonists
Adrenergic Uptake Inhibitors
Analgesics
Analgesics, Non-Narcotic
Anti-Arrhythmia Agents
Anti-Dyskinesia Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anticonvulsants
Antidepressive Agents
Antihypertensive Agents
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Antioxidants
Antiparkinson Agents
Antirheumatic Agents
Autonomic Agents
Carbonic Anhydrase Inhibitors
Cardiovascular Agents
Central Nervous System Agents
Central Nervous System Depressants
Central Nervous System Stimulants
Cholinergic Agents
Cholinergic Antagonists
Cyclooxygenase Inhibitors
Diuretics
Diuretics, Osmotic
Dopamine Agents
Enzyme Inhibitors
Excitatory Amino Acid Agents
Excitatory Amino Acid Antagonists
Ganglionic Blockers
Gastrointestinal Agents
Gout Suppressants
Molecular Mechanisms of Pharmacological Action
Natriuretic Agents
Neuroprotective Agents
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Nicotinic Antagonists
Nitric Oxide Donors
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Psychotropic Drugs
Reproductive Control Agents
Sensory System Agents
Serotonin Agents
Serotonin Uptake Inhibitors
Sympatholytics
Sympathomimetics
Therapeutic Uses
Tocolytic Agents
Vasoconstrictor Agents
Vasodilator Agents

Sponsors listed in this trial

Vanderbilt University
National Heart, Lung, and Blood Institute (NHLBI)

Back to top of Main Content